预测散发性与遗传性甲状腺髓样癌二十年结局
该回顾性研究纳入1995至2015年在Mayo Clinic接受甲状腺切除术的163例甲状腺髓样癌(MTC)患者,中位随访5.5年。多因素分析显示,手术时 gross extrathyroidal extension(ETE)和远处转移(M1)是总生存(OS)和疾病特异性生存(DSS)的显著预测因素,而 gross ETE 和侧颈淋巴结转移(N1b)是局部复发/持续(LR)和远处转移(DM)的显著预测因素。
要点
- 手术时 gross ETE 和 M1 是 OS 和 DSS 的独立预测因素。
- gross ETE 和 N1b 是 LR 和 DM 的独立预测因素。
- 术后降钙素(Ctn)水平与 OS 和 DM 风险显著相关。
核心结论
- 初始手术时的疾病负荷(尤其是 gross ETE、侧颈淋巴结转移和远处转移)以及术后生化反应比人口学因素更重要。
研究设计与样本
- 回顾性研究,纳入1995年1月至2015年12月在Mayo Clinic接受甲状腺切除术的163例MTC患者,其中散发性102例,遗传性61例(MEN 2A 46例,MEN 2B 3例,家族性MTC 12例),中位随访5.5年。
主要发现
- 单因素分析中,年龄>55岁、男性、M1、N1b、gross ETE、AJCC分期3/4、T3/4、肿瘤大小、术后Ctn和CEA是OS和DSS较差的显著预测因素。
- 多因素分析中,gross ETE(HR 4.62,6.58)和M1(HR 5.11,10.45)仍是OS和DSS较差的显著预测因素。
- 年龄>55岁(HR 3.21)、男性(HR 2.42)和术后Ctn(每增加100 pg/mL,HR 1.002)仅对OS较差显著。
- 单因素分析中,男性、M1、N1b、gross ETE、分期3/4、T3/4、肿瘤大小、受累淋巴结数量和术后Ctn是LR和DM的显著预测因素;年龄>55岁对DM额外显著。
- 多因素分析中,gross ETE(HR 3.16,5.93)和N1b(HR 4.31,4.64)仍是LR和DM的显著预测因素;切除/受累淋巴结比值(HR 10.91)额外预测LR,术后Ctn(每增加100 pg/mL,HR 1.003)额外预测DM。
临床怎么用
- 围手术期应进行严格评估,重点关注gross ETE、侧颈淋巴结转移和远处转移以更好预测MTC结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Medullary thyroid cancer (MTC) can be associated with significant morbidity and mortality in advanced cases. Hence, we aimed to identify factors at the time of MTC surgery that predict overall survival (OS), disease-specific survival (DSS), locoregional recurrence/persistence (LR), and distant metastases (DM). Methods: We performed a retrospective study of clinicopathologic, radiological, and laboratory data in MTC patients who underwent thyroidectomy at Mayo Clinic from January 1995 to December 2015. Results: We identified 163 patients (mean age 48.4 years, 48% males), 102 with sporadic MTC and 61 with hereditary disease (n = 46 multiple endocrine neoplasia [MEN] 2A, n = 3 MEN 2B, n = 12 familial MTC) with a median follow-up time of 5.5 years. On univariate analysis, age >55 years, male sex, DM at the time of surgery (M1), lateral neck lymph node (LN) involvement (N1b), gross extrathyroidal extension (ETE), American Joint Committee on Cancer (AJCC) stage 3/4, tumor size (T) 3/4, tumor size, and postoperative calcitonin (Ctn) and carcinoembryonic antigen (CEA) were significant predictors of worse OS and DSS. On multivariable analysis, both gross ETE (hazard ratio [HR] 4.62, 6.58) and M1 (HR 5.11, 10.45) remained significant predictors of worse OS as well as DSS, while age >55 years (HR 3.21), male sex (HR 2.42), and postoperative Ctn (HR 1.002 for every 100 pg/mL increase) were significant only for worse OS. On univariate analysis, male sex, M1, N1b, gross ETE, stage 3/4, T 3/4, tumor size, number of LNs involved, and postoperative Ctn were significant predictors of LR and DM; age >55 years was additionally significant for DM. On multivariable analysis, gross ETE (HR 3.16, 5.93) and N1b (HR 4.31, 4.64) remained significant predictors of LR and DM; ratio of resected/involved LN (HR 10.91) was additionally predictive for LR and postoperative Ctn (HR 1.003 for every 100 pg/mL increase) for DM. Conclusions: Disease burden at initial surgery, especially gross ETE, lateral neck LN involvement, and DM, as well as the biochemical response to surgery appear to be more important than demographic factors in terms of MTC prognosis. These findings highlight the importance of rigorous perioperative assessment to better predict MTC outcomes.
引用
- Kotwal A, Erickson D, Geske JR, et al. Predicting Outcomes in Sporadic and Hereditary Medullary Thyroid Carcinoma over Two Decades. Thyroid. 2020. PMID: 33108969. doi:10.1089/thy.2020.0167
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。